SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-054466
Filing Date
2024-05-07
Accepted
2024-05-07 16:05:38
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q idya-20240331.htm   iXBRL 10-Q 1421695
2 EX-10.1 idya-ex10_1.htm EX-10.1 501069
3 EX-31.1 idya-ex31_1.htm EX-31.1 15345
4 EX-31.2 idya-ex31_2.htm EX-31.2 15010
5 EX-32.1 idya-ex32_1.htm EX-32.1 12394
6 GRAPHIC img189414369_0.jpg GRAPHIC 2663
  Complete submission text file 0000950170-24-054466.txt   7110327

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT idya-20240331.xsd EX-101.SCH 1147315
68 EXTRACTED XBRL INSTANCE DOCUMENT idya-20240331_htm.xml XML 964770
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38915 | Film No.: 24921766
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)